Interesting Engineering on MSN9h
Sniffing out cancer: Scientists test nasal drug for deadly pancreatic tumors
A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
gastroenterologyadvisor1d
Risk for Pancreatitis Does Not Increase With Tirzepatide
Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.
Oncology Nurse Advisor1d
Baseline Vulnerabilities, QOL May Affect Outcomes in Older Pancreatic Cancer Patients
Baseline geriatric vulnerabilities and QOL scores are associated with survival after chemotherapy in older adults with metastatic pancreatic cancer, researchers found.
Hosted on MSN4d
Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer
The findings suggest that "supportive care and management of geriatric vulnerabilities at baseline may improve outcomes and ...
Targeted Oncology6d
Surufatinib Plus TAS-102 Improves Survival in Refractory Metastatic PDAC
Surufatinib plus TAS-102 showed promising survival benefits with manageable toxicity in refractory metastatic PDAC patients, ...